Carcinogenesis Advance Access published online on May 9, 2003
Carcinogenesis, doi:10.1093/carcin/bgg067
© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW
1 Laboratory of Gene Regulation, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece
* Corresponding author. E-mail: vzub{at}eie.gr.
Received 21 January 2003
; revised 10 April 2003
; accepted 16 April 2003
The multistage mouse skin carcinogenesis model although an artificial one, is an ideal system to study the timing of qualitative and quantitative alterations which take place during the different stages of chemical carcinogenesis, allowing analysis of the events that lead to the transition from the stage of initiation to the stage of promotion and finally to the progression of carcinogenesis. In this review, we focus on the role of the H-ras gene and its target molecules during mouse skin carcinogenesis. Besides H-ras, which is a critical target of chemical carcinogens, we report alterations in oncosuppressor genes. Finally, we examine the potential suppression of metastatic dynamics of spindle cells after biological or chemical inhibition of the signalling cascades involved in mouse skin carcinogenesis.
Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Syed, S. B. Cheepala, J. N. Gill, J. Stein, C. A. Nathan, J. DiGiovanni, V. Batra, P. Adegboyega, H. E. Kleiner, and J. L. Clifford All-Trans Retinoic Acid Suppresses Stat3 Signaling during Skin Carcinogenesis Cancer Prevention Research, October 1, 2009; 2(10): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fiory, P. Formisano, G. Perruolo, and F. Beguinot Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E592 - E601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liontos, M. Koutsami, M. Sideridou, K. Evangelou, D. Kletsas, B. Levy, A. Kotsinas, O. Nahum, V. Zoumpourlis, M. Kouloukoussa, et al. Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior Cancer Res., November 15, 2007; 67(22): 10899 - 10909. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ouyang, Y. Hu, J. Li, M. Ding, Y. Lu, D. Zhang, Y. Yan, L. Song, Q. Qu, D. Desai, et al. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells Carcinogenesis, October 1, 2007; 28(10): 2218 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Chung, J. H. Park, M. J. Kim, H. O. Kim, J. K. Hwang, S. K. Lee, and K. K. Park Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-{kappa}B Carcinogenesis, June 1, 2007; 28(6): 1224 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ruiz, M. Santos, M. F. Lara, C. Segrelles, C. Ballestin, and J. M. Paramio Unexpected Roles for pRb in Mouse Skin Carcinogenesis Cancer Res., November 1, 2005; 65(21): 9678 - 9686. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marwaha, Y.-H. Chen, E. Helms, S. Arad, H. Inoue, E. Bord, R. Kishore, R. D. Sarkissian, B. A. Gilchrest, and D. A. Goukassian T-oligo Treatment Decreases Constitutive and UVB-induced COX-2 Levels through p53- and NF{kappa}B-dependent Repression of the COX-2 Promoter J. Biol. Chem., September 16, 2005; 280(37): 32379 - 32388. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Papassava, V. G. Gorgoulis, D. Papaevangeliou, S. Vlahopoulos, H. van Dam, and V. Zoumpourlis Overexpression of Activating Transcription Factor-2 Is Required for Tumor Growth and Progression in Mouse Skin Tumors Cancer Res., December 1, 2004; 64(23): 8573 - 8584. [Abstract] [Full Text] [PDF] |
||||




